The Apple Watch is perhaps one of the wearables the most popular of the moment, and there is no denying that it improves people’s lives (or saves them, for that matter). Say what you want about Apple and its gadgets, but all the successes of the Apple Watch deserve attention.
The Food and Drug Administration (FDA) has indeed approved the use of the Apple Watch for monitoring patients with Parkinson’s disease. According to Reuters, permission has been granted to Rune Labs – a startup from the San Francisco-based healthcare industry — to run special software on the watch to track symptoms of Parkinson’s disease.
” With all the data we will collect and the patients we will reach through this authorization, we will ensure that the right participants enroll in the trials. said Brian Pepin, CEO and Founder of Rune Labs, in a statement. This will make trials more efficient and get drugs to market faster, he added.
Patients have been using the app for about a year, but FDA approval means clinicians have ways to charge patients when they review watch data and allows results to be used as referral data. clinical trials of various treatments for Parkinson’s disease.
The software in question can discern and track common symptoms of the disease such as tremors, involuntary or slow movements, rigidity and poor balance, etc. Apple added hard-drop detection software to its Watch Series 4 in 2018, and later released the software as part of its open-source ResearchKit software. The developers were thus able use the Movement Disorder API to build watchOS apps and solutions to track various diseases manifested by symptoms involving movement abnormalities.
A medical supplement
The use ofwearablesto track these disorders isn’t new, but Rune Lab’s solution is the first designed for commercial applications. The idea is to track the patient’s condition over a period of time and allow doctors and specialists to access this data.
Of course, the application has its limits, but it is designed to serve as a complement to the classic in-person medical examination. This isn’t the first Apple Watch feature to receive FDA approval. Earlier this month, the administration approved watchOS’ “Atrial Fibrillation History” feature, which allows people 22 and older to use the watch to monitor their heart condition.